Inhibition of EphB4-ephrin-B2 interaction by PEG-TNYL-RAW could also be useful to inhibit the growth of cancer cells in which EphB4-ephrin-B2 interaction promotes tumorigenesis, such as melanoma cells [9], [10], [11]. Here, EFNB2 is linked to melanoma.